|
|
| CAS-Nr. | 103-75-3 |
| Bezeichnung: | 2-Ethoxy-3,4-dihydro-2H-pyran |
| Englisch Name: | 2-ETHOXY-3,4-DIHYDRO-2H-PYRAN |
| Synonyma: | 3,4-Dihydro-2H-pyran-2-ylethylether;2-Ethoxy-3,4-dihydro-2H-pyran
2-Ethoxypyran;Ethoxydihydropyran;2-Ethoxydihydropyran;2-ETHOXY-3,4-DIHYDROPYRAN;2-Ethoxy-3,4-dihydro-2-pyran;2-ethoxy-3,4-dihydro-2h-pyra;2-Ethoxy-2,3-dihydro-4H-pyran;2-ethoxy-2,3-dihydro(4h)pyran;2-ETHOXY-3,4-DIHYDRO-2H-PYRAN;3,4-DIHYDRO-2-ETHOXY-2H-PYRAN |
| CBNumber: | CB7304529 |
| Summenformel: | C7H12O2 |
| Molgewicht: | 128.17 |
| MOL-Datei: | 103-75-3.mol |
|
|
|
|
| 2-Ethoxy-3,4-dihydro-2H-pyran physikalisch-chemischer Eigenschaften |
| Siedepunkt:: |
42 °C16 mm Hg(lit.)
|
|
| Dichte: |
0.957 g/mL at 25 °C(lit.)
|
|
| Brechungsindex: |
n20/D 1.439(lit.)
|
|
|
|
|
|
|
|
|
2-Ethoxy-3,4-dihydro-2H-pyran Chemische Eigenschaften,Einsatz,Produktion Methoden |
Allgemeine Beschreibung
Colorless liquid. Floats on water. |
|
Reaktivität anzeigen
Ethers, such as 2-ETHOXY-3,4-DIHYDRO-2H-PYRAN can act as bases. They form salts with strong acids and addition complexes with Lewis acids. The complex between diethyl ether and boron trifluoride is an example. Ethers may react violently with strong oxidizing agents. In other reactions, which typically involve the breaking of the carbon-oxygen bond, ethers are relatively inert. |
|
Health Hazard
Contact with liquid irritates eyes. Also irritates skin on prolonged contact. |
|
R-Sätze Betriebsanweisung:
R10:Entzündlich.
R36/38:Reizt die Augen und die Haut. |
|
S-Sätze Betriebsanweisung:
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren. |
|
|
| 2-Ethoxy-3,4-dihydro-2H-pyran Upstream-Materialien And Downstream Produkte |
Upstream-Materialien
|
Downstream Produkte
Glutardialdehyd
|
| 2-Ethoxy-3,4-dihydro-2H-pyran Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 43)Lieferanten |
|
|
|
|
|
| 103-75-3(2-Ethoxy-3,4-dihydro-2H-pyran)Verwandte Suche: |
|
3,4-Dihydro-2H-pyran
1a(S)α,1bβ,2β,5aβ,6β,6aα-Hexahydro-6-[(4-hydroxybenzoyl)oxy]-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl-β-D-glucopyranosid
2-Ethoxy-3,4-dihydro-2H-pyran
[1S-(1α,4aα,6α,7α,7aα)]-1-(β-D-Glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methylcyclopenta[c]pyran-4-carbonsure
β-D-Glucopyranosid, 1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl, 6-(3-Phenyl-2-propenoat), [1aS-[1aα,1bβ,2β(E),5aβ,6β,6aα-
2-(3,4-Dihydroxyphenyl)ethyl-[2S-(2α,3E,4β)]-3-ethyliden-2-(β-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-acetat
[1aS-(1aα,1bβ,2β,5aβ,6β,6aα)]-1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl-β-D-glucopyranosid
(5R-trans)-6-(β-D-Glucopyranosyloxy)-5,6-dihydro-5-vinyl-1H,3H-pyrano[3,4-c]pyran-1-on
Sisomicin
Methyl-[1S-(1α,4aα,6α,7α,7aα)]-1-(β-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methylcyclopenta[c]pyran-4-carboxylat
[1S-[1α,4aα,5α,7α(E),7aα]]-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[(allyl-1-oxo-3-phenyl)oxy]cyclopenta[c]pyran-1-yl-β-D-glucopyranosid
|
|
2-ethoxy-2,3-dihydro(4h)pyran
2-Ethoxy-2,3-dihydro-4H-pyran
2-Ethoxy-2,3-dihydro-gamma-pyran
2-ethoxy-3,4-dihydro-2h-pyra
2-Ethoxy-3,4-dihydro-2-pyran
2-Ethoxydihydropyran
2-ethoxydihydropyran,inpregnancydiagnosis
2-Ethoxypyran
Ethoxydihydropyran
2-Ethoxy-3，4-dihydro-1，2-pyran
2-ETHOXY-3,4-DIHYDRO-2H-PYRAN
2-ETHOXY-3,4-DIHYDROPYRAN
103-75-3
3,4-DIHYDRO-2-ETHOXY-2H-PYRAN
3,4-dihydro-2H-pyran-2-yl ethyl ether
3 4-DIHYDRO-2-ETHOXY-2H-PYRAN 98%
2-ETHOXY-3,4-DIHYDRO-2H-PYRAN 98+%
2-Ethoxy-3,4-dihydro-(2H)-pyrane
2H-Pyran, 2-ethoxy-3,4-dihydro-
C7H412O2
Alphabetic
D
DID - DIN
|
| Urheberrecht 2009 © ChemicalBook. Alle Rechte vorbehalten. |